BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10667419)

  • 1. Decreased expression of protectin (CD59) in gut epithelium in ulcerative colitis and Crohn's disease.
    Scheinin T; Böhling T; Halme L; Kontiainen S; Bjørge L; Meri S
    Hum Pathol; 1999 Dec; 30(12):1427-30. PubMed ID: 10667419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract.
    Berstad AE; Brandtzaeg P
    Gut; 1998 Apr; 42(4):522-9. PubMed ID: 9616315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.
    Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
    Gut; 1992 Jul; 33(7):902-8. PubMed ID: 1379568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
    Bendixen G
    Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
    Selby WS; Janossy G; Mason DY; Jewell DP
    Clin Exp Immunol; 1983 Sep; 53(3):614-8. PubMed ID: 6577996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
    Allison MC; Cornwall S; Poulter LW; Dhillon AP; Pounder RE
    Gut; 1988 Nov; 29(11):1531-8. PubMed ID: 3209109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
    Gehlert T; Devergne O; Niedobitek G
    J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.
    Rosenberg WM; Prince C; Kaklamanis L; Fox SB; Jackson DG; Simmons DL; Chapman RW; Trowell JM; Jewell DP; Bell JI
    Lancet; 1995 May; 345(8959):1205-9. PubMed ID: 7537840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.
    Halstensen TS; Mollnes TE; Fausa O; Brandtzaeg P
    Gut; 1989 Mar; 30(3):361-6. PubMed ID: 2707635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
    Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
    Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.
    Singer II; Kawka DW; Schloemann S; Tessner T; Riehl T; Stenson WF
    Gastroenterology; 1998 Aug; 115(2):297-306. PubMed ID: 9679035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.
    Iizuka M; Chiba M; Yukawa M; Nakagomi T; Fukushima T; Watanabe S; Nakagomi O
    Gut; 2000 Feb; 46(2):163-9. PubMed ID: 10644308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K; Youngman KR; West GA; Fiocchi C
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
    Ueyama H; Kiyohara T; Sawada N; Isozaki K; Kitamura S; Kondo S; Miyagawa J; Kanayama S; Shinomura Y; Ishikawa H; Ohtani T; Nezu R; Nagata S; Matsuzawa Y
    Gut; 1998 Jul; 43(1):48-55. PubMed ID: 9771405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.